• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$36.90 $0.44 (1.21%)

REAL-TIME: Last trade at

AmerisourceBergen Corp.

NYSE:ABC

Equity Research on AmerisourceBergen Corporation and Omnicare Inc. - Drug Wholesalers Target Expansion

Goldman Sachs Adds AmerisourceBergen (ABC) to Conviction Buy, Removes McKesson (MCK)

AmerisourceBergen upgraded to Conviction Buy from Buy at Goldman

Perception, Opportunity in Volatility - Research & Analysis on Walgreen Company and AmerisourceBergen Corp.

Perception, Opportunity in Volatility - Research & Analysis on Walgreen Company and AmerisourceBergen Corp.

AmerisourceBergen appoints CFO

AmerisourceBergen Names Tim Guttman CFO

AmerisourceBergen (ABC) Makes VP Tim Guttman Permanent CFO

AmerisourceBergen Names Tim G. Guttman Senior Vice President and Chief Financial Officer

AmerisourceBergen approves new $750M buyback

AmerisourceBergen sets new stock buyback at $750M

AmerisourceBergen Board Approves Quarterly Dividend, $750 Mln Share Buyback

AmerisourceBergen (ABC) Approves New $750M Buyback

AmerisourceBergen Corp. (ABC) Declares $0.13 Quarterly Dividend; 1.4% Yield

AmerisourceBergen Authorizes a New $750 Million Share Repurchase Program and Approves Quarterly Dividend

ABC Takes Over World Courier - Analyst Blog

ABC Takes Over World Courier

Higher Medical Claims Now Sicken Cigna, Health Net

AmerisourceBergen wraps up World Courier acquisition

AmerisourceBergen completes acquisition of World Courrier Group

AmerisourceBergen Completes Acquisition of World Courier Group, Inc.

AmerisourceBergen sole distributor for BTG kidney failure treatment

Express Scripts Seeks Bids For Potential $20 Billion/Year Contract

AmerisourceBergen's CEO Discusses Q2 2012 Results - Earnings Call Transcript

AmerisourceBergen 1st-qtr profit slips 1 percent

AmerisourceBergen Posts Modest 2Q - Analyst Blog

AmerisourceBergen Posts Modest 2Q

AmerisourceBergen attributes growth to specialty biz

10 Stock Charts to Watch for Opportunity

AmerisourceBergen Q2 results decent, Medco still overhang, says Leerink

Amerisourcebergen Corp. (ABC) Reports In-Line Q2 EPS

AmerisourceBergen sees FY12 EPS $2.74-$2.84, consensus $2.82

AmerisourceBergen Reports $0.81 in Diluted EPS for the March Quarter

Companies reporting Before the Market Open on Thursday, April 26

AmerisourceBergen: Earnings Preview

Earnings Preview: AmerisourceBergen - Analyst Blog

Earnings Preview: AmerisourceBergen - Analyst Blog

Earnings Preview: AmerisourceBergen

Forbes Earnings Preview: AmerisourceBergen

AmerisourceBergen Q2 results to impact investor sentiment, says Leerink

See More Articles...